Clinical Trials Directory

Trials / Completed

CompletedNCT03506152

Evaluation of Serum Procalcitonin in Critically Ill Patients With Suspected Sepsis

Prospective Evaluation of Serum Procalcitonin in Critically Ill Patients With Suspected Sepsis- Experience From a Tertiary Care Hospital in Pakistan

Status
Completed
Phase
Study type
Observational
Enrollment
103 (actual)
Sponsor
Aga Khan University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers

Summary

Procalcitonin is a promising marker of sepsis in critically ill patients. Procalcitonin have better diagnostic accuracy compared to White blood cell count and C - reactive protein. Investigators propose that adding Procalcitonin to the list of standard laboratory work up of critically ill patients with suspected sepsis could increase diagnostic accuracy leading to better patient care.

Detailed description

Background: Sepsis is the leading cause of mortality in critically ill patients. Procalcitonin (PCT) is a promising marker for identification of bacterial sepsis. The aim of this study was to determine the diagnostic accuracy of serum PCT concentration in patients with suspected sepsis admitted to mixed medical-surgical Intensive care unit (ICU). Material and Methods: A cross-sectional study conducted at section of Chemical Pathology, Department of Pathology and Laboratory Medicine and ICU. Patients with suspected sepsis were included, serum PCT cut off ≥0.5 ng /ml was taken for diagnosing sepsis. Diagnostic accuracy was measured in terms of sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) taking blood culture as gold standard. Furthermore, different cut offs were compared by using receiver operating characteristic curves (ROC). Data analysis was done on SPSS version.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSerum ProcalcitoninSeven ml of blood was drawn in gel separator tubes within 24 hours of admission in ICU for Procalcitonin determination

Timeline

Start date
2014-01-01
Primary completion
2015-12-03
Completion
2015-12-03
First posted
2018-04-24
Last updated
2018-04-24

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT03506152. Inclusion in this directory is not an endorsement.

Evaluation of Serum Procalcitonin in Critically Ill Patients With Suspected Sepsis (NCT03506152) · Clinical Trials Directory